The Function and Therapeutic Potential of Long Non-coding RNAs in Cardiovascular Development and Disease

Molecular Therapy Nucleic Acids

Volumn 8, Issue , 2017, Pages 494-507

  Gomes, Clarissa P C ^a   Spencer, Helen ^b   Ford, Kerrie L ^c   Michel, Lauriane Y M ^d   Baker, Andrew H ^b   Emanueli, Costanza ^c,e   Balligand, Jean Luc ^d   Devaux, Yvan ^a  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

cardiovascular development; cardiovascular disease; cardiovascular system; long non coding RNAs; non coding RNAs; RNAs; therapy; transcriptomics; vascular disease

Indexed keywords

LONG UNTRANSLATED RNA;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CORONARY ARTERY DISEASE; GENE FUNCTION; HEART DEVELOPMENT; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIA; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 85029328956     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1016/j.omtn.2017.07.014     Document Type: Review

References (178)

1. Ozsolak, F., Milos, P.M., RNA sequencing: advances, challenges and opportunities. Nat. Rev. Genet. 12 (2011), 87–98.
2. Devaux, Y., Zangrando, J., Schroen, B., Creemers, E.E., Pedrazzini, T., Chang, C.P., Dorn, G.W. 2nd, Thum, T., Heymans, S., Cardiolinc network. Long noncoding RNAs in cardiac development and ageing. Nat. Rev. Cardiol. 12 (2015), 415–425.
3. Bär, C., Chatterjee, S., Thum, T., Long noncoding RNAs in cardiovascular pathology, diagnosis, and therapy. Circulation 134 (2016), 1484–1499.
4. Devaux, Y., Transcriptome of blood cells as a reservoir of cardiovascular biomarkers. Biochim. Biophys. Acta 1864 (2017), 209–216.
5. Boon, R.A., Jaé, N., Holdt, L., Dimmeler, S., Long noncoding RNAs: From clinical genetics to therapeutic targets?. J. Am. Coll. Cardiol. 67 (2016), 1214–1226.
6. Johnsson, P., Lipovich, L., Grandér, D., Morris, K.V., Evolutionary conservation of long non-coding RNAs; sequence, structure, function. Biochim. Biophys. Acta 1840 (2014), 1063–1071.
7. Willingham, A.T., Orth, A.P., Batalov, S., Peters, E.C., Wen, B.G., Aza-Blanc, P., Hogenesch, J.B., Schultz, P.G., A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science 309 (2005), 1570–1573.
8. Wang, P., Xue, Y., Han, Y., Lin, L., Wu, C., Xu, S., Jiang, Z., Xu, J., Liu, Q., Cao, X., The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation. Science 344 (2014), 310–313.
9. Wang, K.C., Chang, H.Y., Molecular mechanisms of long noncoding RNAs. Mol. Cell 43 (2011), 904–914.
10. Ørom, U.A., Derrien, T., Beringer, M., Gumireddy, K., Gardini, A., Bussotti, G., Lai, F., Zytnicki, M., Notredame, C., Huang, Q., et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 143 (2010), 46–58.
11. Hansen, T.B., Jensen, T.I., Clausen, B.H., Bramsen, J.B., Finsen, B., Damgaard, C.K., Kjems, J., Natural RNA circles function as efficient microRNA sponges. Nature 495 (2013), 384–388.
12. Quinn, J.J., Chang, H.Y., Unique features of long non-coding RNA biogenesis and function. Nat. Rev. Genet. 17 (2016), 47–62.
13. Zhang, K., Shi, Z.M., Chang, Y.N., Hu, Z.M., Qi, H.X., Hong, W., The ways of action of long non-coding RNAs in cytoplasm and nucleus. Gene 547 (2014), 1–9.
14. Rashid, F., Shah, A., Shan, G., Long non-coding RNAs in the cytoplasm. Genomics Proteomics Bioinformatics 14 (2016), 73–80.
15. Viereck, J., Kumarswamy, R., Foinquinos, A., Xiao, K., Avramopoulos, P., Kunz, M., Dittrich, M., Maetzig, T., Zimmer, K., Remke, J., et al. Long noncoding RNA Chast promotes cardiac remodeling. Sci. Transl. Med., 8, 2016, 326ra22.
16. Meng, L., Ward, A.J., Chun, S., Bennett, C.F., Beaudet, A.L., Rigo, F., Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. Nature 518 (2015), 409–412.
17. Michalik, K.M., You, X., Manavski, Y., Doddaballapur, A., Zörnig, M., Braun, T., John, D., Ponomareva, Y., Chen, W., Uchida, S., et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ. Res. 114 (2014), 1389–1397.
18. Krieg, A.M., Targeting LDL cholesterol with LNA. Mol. Ther. Nucleic Acids, 1, 2012, e6.
19. Wheeler, T.M., Leger, A.J., Pandey, S.K., MacLeod, A.R., Nakamori, M., Cheng, S.H., Wentworth, B.M., Bennett, C.F., Thornton, C.A., Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 488 (2012), 111–115.
20. Guttman, M., Donaghey, J., Carey, B.W., Garber, M., Grenier, J.K., Munson, G., Young, G., Lucas, A.B., Ach, R., Bruhn, L., et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477 (2011), 295–300.
21. Ounzain, S., Pezzuto, I., Micheletti, R., Burdet, F., Sheta, R., Nemir, M., Gonzales, C., Sarre, A., Alexanian, M., Blow, M.J., et al. Functional importance of cardiac enhancer-associated noncoding RNAs in heart development and disease. J. Mol. Cell. Cardiol. 76 (2014), 55–70.
22. Matkovich, S.J., Edwards, J.R., Grossenheider, T.C., de Guzman Strong, C., Dorn, G.W. 2nd, Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs. Proc. Natl. Acad. Sci. USA 111 (2014), 12264–12269.
23. Werber, M., Wittler, L., Timmermann, B., Grote, P., Herrmann, B.G., The tissue-specific transcriptomic landscape of the mid-gestational mouse embryo. Development 141 (2014), 2325–2330.
24. Xue, Z., Hennelly, S., Doyle, B., Gulati, A.A., Novikova, I.V., Sanbonmatsu, K.Y., Boyer, L.A., A G-rich motif in the lncRNA Braveheart interacts with a zinc-finger transcription factor to specify the cardiovascular lineage. Mol. Cell 64 (2016), 37–50.
25. Klattenhoff, C.A., Scheuermann, J.C., Surface, L.E., Bradley, R.K., Fields, P.A., Steinhauser, M.L., Ding, H., Butty, V.L., Torrey, L., Haas, S., et al. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell 152 (2013), 570–583.
26. Grote, P., Wittler, L., Hendrix, D., Koch, F., Währisch, S., Beisaw, A., Macura, K., Bläss, G., Kellis, M., Werber, M., Herrmann, B.G., The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev. Cell 24 (2013), 206–214.
27. Ounzain, S., Micheletti, R., Beckmann, T., Schroen, B., Alexanian, M., Pezzuto, I., Crippa, S., Nemir, M., Sarre, A., Johnson, R., et al. Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs. Eur. Heart J., 36, 2015 353–68a.
28. Ounzain, S., Micheletti, R., Arnan, C., Plaisance, I., Cecchi, D., Schroen, B., Reverter, F., Alexanian, M., Gonzales, C., Ng, S.Y., et al. CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis. J. Mol. Cell. Cardiol. 89:Pt A (2015), 98–112.
29. Wang, J., Geng, Z., Weng, J., Shen, L., Li, M., Cai, X., Sun, C., Chu, M., Microarray analysis reveals a potential role of lncRNAs expression in cardiac cell proliferation. BMC Dev. Biol., 16, 2016, 41.
30. Korostowski, L., Sedlak, N., Engel, N., The Kcnq1ot1 long non-coding RNA affects chromatin conformation and expression of Kcnq1, but does not regulate its imprinting in the developing heart. PLoS Genet., 8, 2012, e1002956.
31. Vausort, M., Wagner, D.R., Devaux, Y., Long noncoding RNAs in patients with acute myocardial infarction. Circ. Res. 115 (2014), 668–677.
32. VanBuren, P., Harris, D.E., Alpert, N.R., Warshaw, D.M., Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. Circ. Res. 77 (1995), 439–444.
33. Haddad, F., Bodell, P.W., Qin, A.X., Giger, J.M., Baldwin, K.M., Role of antisense RNA in coordinating cardiac myosin heavy chain gene switching. J. Biol. Chem. 278 (2003), 37132–37138.
34. Reiser, P.J., Portman, M.A., Ning, X.H., Schomisch Moravec, C., Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. Am. J. Physiol. Heart Circ. Physiol. 280 (2001), H1814–H1820.
35. Haddad, F., Qin, A.X., Bodell, P.W., Jiang, W., Giger, J.M., Baldwin, K.M., Intergenic transcription and developmental regulation of cardiac myosin heavy chain genes. Am. J. Physiol. Heart Circ. Physiol. 294 (2008), H29–H40.
36. Haddad, F., Qin, A.X., Bodell, P.W., Zhang, L.Y., Guo, H., Giger, J.M., Baldwin, K.M., Regulation of antisense RNA expression during cardiac MHC gene switching in response to pressure overload. Am. J. Physiol. Heart Circ. Physiol. 290 (2006), H2351–H2361.
37. Bell, R.D., Long, X., Lin, M., Bergmann, J.H., Nanda, V., Cowan, S.L., Zhou, Q., Han, Y., Spector, D.L., Zheng, D., Miano, J.M., Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 1249–1259.
38. Boulberdaa, M., Scott, E., Ballantyne, M., Garcia, R., Descamps, B., Angelini, G.D., Brittan, M., Hunter, A., McBride, M., McClure, J., et al. A role for the long noncoding RNA SENCR in commitment and function of endothelial cells. Mol. Ther. 24 (2016), 978–990.
39. Ballantyne, M.D., Pinel, K., Dakin, R., Vesey, A.T., Diver, L., Mackenzie, R., Garcia, R., Welsh, P., Sattar, N., Hamilton, G., et al. Smooth muscle enriched long noncoding RNA (SMILR) regulates cell proliferation. Circulation 133 (2016), 2050–2065.
40. van den Boom, M., Sarbia, M., von Wnuck Lipinski, K., Mann, P., Meyer-Kirchrath, J., Rauch, B.H., Grabitz, K., Levkau, B., Schrör, K., Fischer, J.W., Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: possible implications for vein graft stenosis. Circ. Res. 98 (2006), 36–44.
41. Tripathi, V., Ellis, J.D., Shen, Z., Song, D.Y., Pan, Q., Watt, A.T., Freier, S.M., Bennett, C.F., Sharma, A., Bubulya, P.A., et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 39 (2010), 925–938.
42. Kurian, L., Aguirre, A., Sancho-Martinez, I., Benner, C., Hishida, T., Nguyen, T.B., Reddy, P., Nivet, E., Krause, M.N., Nelles, D.A., et al. Identification of novel long noncoding RNAs underlying vertebrate cardiovascular development. Circulation 131 (2015), 1278–1290.
43. Zou, Z.Q., Xu, J., Li, L., Han, Y.S., Down-regulation of SENCR promotes smooth muscle cells proliferation and migration in db/db mice through up-regulation of FoxO1 and TRPC6. Biomed. Pharmacother. 74 (2015), 35–41.
44. Ratajczak, M.Z., Igf2-H19, an imprinted tandem gene, is an important regulator of embryonic development, a guardian of proliferation of adult pluripotent stem cells, a regulator of longevity, and a ‘passkey’ to cancerogenesis. Folia Histochem. Cytobiol. 50 (2012), 171–179.
45. Devlin, A.M., Bottiglieri, T., Domann, F.E., Lentz, S.R., Tissue-specific changes in H19 methylation and expression in mice with hyperhomocysteinemia. J. Biol. Chem. 280 (2005), 25506–25511.
46. Ding, G.-L., Wang, F.-F., Shu, J., Tian, S., Jiang, Y., Zhang, D., Wang, N., Luo, Q., Zhang, Y., Jin, F., et al. Transgenerational glucose intolerance with Igf2/H19 epigenetic alterations in mouse islet induced by intrauterine hyperglycemia. Diabetes 61 (2012), 1133–1142.
47. Gao, W., Zhu, M., Wang, H., Zhao, S., Zhao, D., Yang, Y., Wang, Z.M., Wang, F., Yang, Z.J., Lu, X., Wang, L.S., Association of polymorphisms in long non-coding RNA H19 with coronary artery disease risk in a Chinese population. Mutat. Res. 772 (2015), 15–22.
48. Greco, S., Zaccagnini, G., Perfetti, A., Fuschi, P., Valaperta, R., Voellenkle, C., Castelvecchio, S., Gaetano, C., Finato, N., Beltrami, A.P., et al. Long noncoding RNA dysregulation in ischemic heart failure. J. Transl. Med., 14, 2016, 183.
49. Han, D.K., Khaing, Z.Z., Pollock, R.A., Haudenschild, C.C., Liau, G., H19, a marker of developmental transition, is reexpressed in human atherosclerotic plaques and is regulated by the insulin family of growth factors in cultured rabbit smooth muscle cells. J. Clin. Invest. 97 (1996), 1276–1285.
50. Kim, D.K., Zhang, L., Dzau, V.J., Pratt, R.E., H19, a developmentally regulated gene, is reexpressed in rat vascular smooth muscle cells after injury. J. Clin. Invest. 93 (1994), 355–360.
51. Li, L., Xie, J., Zhang, M., Wang, S., Homocysteine harasses the imprinting expression of IGF2 and H19 by demethylation of differentially methylated region between IGF2/H19 genes. Acta Biochim. Biophys. Sin. (Shanghai) 41 (2009), 464–471.
52. Liu, L., An, X., Li, Z., Song, Y., Li, L., Zuo, S., Liu, N., Yang, G., Wang, H., Cheng, X., et al. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy. Cardiovasc. Res. 111 (2016), 56–65.
53. Shao, W.-J., Tao, L.-Y., Gao, C., Xie, J.-Y., Zhao, R.-Q., Alterations in methylation and expression levels of imprinted genes H19 and Igf2 in the fetuses of diabetic mice. Comp. Med. 58 (2008), 341–346.
54. Tragante, V., Barnes, M.R., Ganesh, S.K., Lanktree, M.B., Guo, W., Franceschini, N., Smith, E.N., Johnson, T., Holmes, M.V., Padmanabhan, S., et al. Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci. Am. J. Hum. Genet. 94 (2014), 349–360.
55. Gao, Y., Wu, F., Zhou, J., Yan, L., Jurczak, M.J., Lee, H.-Y., Yang, L., Mueller, M., Zhou, X.B., Dandolo, L., et al. The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells. Nucleic Acids Res. 42 (2014), 13799–13811.
56. Kanwar, Y.S., Pan, X., Lin, S., Kumar, A., Wada, J., Haas, C.S., Liau, G., Lomasney, J.W., Imprinted mesodermal specific transcript (MEST) and H19 genes in renal development and diabetes. Kidney Int. 63 (2003), 1658–1670.
57. Yu, L., Chen, M., Zhao, D., Yi, P., Lu, L., Han, J., Zheng, X., Zhou, Y., Li, L., The H19 gene imprinting in normal pregnancy and pre-eclampsia. Placenta 30 (2009), 443–447.
58. Hadji, F., Boulanger, M.-C., Guay, S.-P., Gaudreault, N., Amellah, S., Mkannez, G., Bouchareb, R., Marchand, J.T., Nsaibia, M.J., Guauque-Olarte, S., et al. Altered DNA methylation of long noncoding RNA H19 in calcific aortic valve disease promotes mineralization by silencing NOTCH1. Circulation 134 (2016), 1848–1862.
59. Kallen, A.N., Zhou, X.B., Xu, J., Qiao, C., Ma, J., Yan, L., Lu, L., Liu, C., Yi, J.S., Zhang, H., et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol. Cell 52 (2013), 101–112.
60. Chen, K.-C., Hsieh, I.C., Hsi, E., Wang, Y.-S., Dai, C.-Y., Chou, W.-W., Juo, S.H., Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1. J. Cell Sci. 124 (2011), 4115–4124.
61. Satoh, M., Tabuchi, T., Minami, Y., Takahashi, Y., Itoh, T., Nakamura, M., Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: effect of statins on let-7i and Toll-like receptor 4 signal. Immunobiology 217 (2012), 533–539.
62. Ding, Z., Wang, X., Schnackenberg, L., Khaidakov, M., Liu, S., Singla, S., Dai, Y., Mehta, J.L., Regulation of autophagy and apoptosis in response to ox-LDL in vascular smooth muscle cells, and the modulatory effects of the microRNA hsa-let-7 g. Int. J. Cardiol. 168 (2013), 1378–1385.
63. Bao, M.H., Zhang, Y.W., Lou, X.Y., Cheng, Y., Zhou, H.H., Protective effects of let-7a and let-7b on oxidized low-density lipoprotein induced endothelial cell injuries. PLoS ONE, 9, 2014, e106540.
64. Qin, B., Xiao, B., Liang, D., Li, Y., Jiang, T., Yang, H., MicroRNA let-7c inhibits Bcl-xl expression and regulates ox-LDL-induced endothelial apoptosis. BMB Rep. 45 (2012), 464–469.
65. Fichtlscherer, S., De Rosa, S., Fox, H., Schwietz, T., Fischer, A., Liebetrau, C., Weber, M., Hamm, C.W., Röxe, T., Müller-Ardogan, M., et al. Circulating microRNAs in patients with coronary artery disease. Circ. Res. 107 (2010), 677–684.
66. Voellenkle, C., Garcia-Manteiga, J.M., Pedrotti, S., Perfetti, A., De Toma, I., Da Silva, D., Maimone, B., Greco, S., Fasanaro, P., Creo, P., et al. Implication of long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. Sci. Rep., 6, 2016, 24141.
67. Tao, H., Cao, W., Yang, J.J., Shi, K.H., Zhou, X., Liu, L.P., Li, J., Long noncoding RNA H19 controls DUSP5/ERK1/2 axis in cardiac fibroblast proliferation and fibrosis. Cardiovasc. Pathol. 25 (2016), 381–389.
68. Nemecz, M., Alexandru, N., Tanko, G., Georgescu, A., Role of microRNA in endothelial dysfunction and hypertension. Curr. Hypertens. Rep., 18, 2016, 87.
69. Wang, Y.N., Shan, K., Yao, M.D., Yao, J., Wang, J.J., Li, X., Liu, B., Zhang, Y.Y., Ji, Y., Jiang, Q., Yan, B., Long noncoding RNA-GAS5: a novel regulator of hypertension-induced vascular remodeling. Hypertension 68 (2016), 736–748.
70. Leung, A., Trac, C., Jin, W., Lanting, L., Akbany, A., Sætrom, P., Schones, D.E., Natarajan, R., Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ. Res. 113 (2013), 266–278.
71. Liu, X., Cheng, Y., Zhang, S., Lin, Y., Yang, J., Zhang, C., A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ. Res. 104 (2009), 476–487.
72. Zhu, N., Zhang, D., Chen, S., Liu, X., Lin, L., Huang, X., Guo, Z., Liu, J., Wang, Y., Yuan, W., Qin, Y., Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis 215 (2011), 286–293.
73. Holdt, L.M., Hoffmann, S., Sass, K., Langenberger, D., Scholz, M., Krohn, K., Finstermeier, K., Stahringer, A., Wilfert, W., Beutner, F., et al. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet., 9, 2013, e1003588.
74. Wang, J., Ma, R., Ma, W., Chen, J., Yang, J., Xi, Y., Cui, Q., LncDisease: a sequence based bioinformatics tool for predicting lncRNA-disease associations. Nucleic Acids Res., 44, 2016, e90.
75. Ross, R., Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 340 (1999), 115–126.
76. Shan, K., Jiang, Q., Wang, X.Q., Wang, Y.N.Z., Yang, H., Yao, M.D., Liu, C., Li, X.M., Yao, J., Liu, B., et al. Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction. Cell Death Dis., 7, 2016, e2248.
77. Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M.J., Kenzelmann-Broz, D., Khalil, A.M., Zuk, O., Amit, I., Rabani, M., et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142 (2010), 409–419.
78. Wu, G., Cai, J., Han, Y., Chen, J., Huang, Z.-P., Chen, C., Cai, Y., Huang, H., Yang, Y., Liu, Y., et al. LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circulation 130 (2014), 1452–1465.
79. Tang, S.S., Cheng, J., Cai, M.Y., Yang, X.L., Liu, X.G., Zheng, B.Y., Xiong, X.D., Association of lincRNA-p21 haplotype with coronary artery disease in a Chinese Han population. Dis. Markers, 2016, 2016, 9109743.
80. Vigetti, D., Deleonibus, S., Moretto, P., Bowen, T., Fischer, J.W., Grandoch, M., Oberhuber, A., Love, D.C., Hanover, J.A., Cinquetti, R., et al. Natural antisense transcript for hyaluronan synthase 2 (HAS2-AS1) induces transcription of HAS2 via protein O-GlcNAcylation. J. Biol. Chem. 289 (2014), 28816–28826.
81. Carpenter, S., Aiello, D., Atianand, M.K., Ricci, E.P., Gandhi, P., Hall, L.L., Byron, M., Monks, B., Henry-Bezy, M., Lawrence, J.B., et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science 341 (2013), 789–792.
82. Rapicavoli, N.A., Qu, K., Zhang, J., Mikhail, M., Laberge, R.-M., Chang, H.Y., A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. eLife, 2, 2013, e00762.
83. Liu, Y., Ferguson, J.F., Xue, C., Ballantyne, R.L., Silverman, I.M., Gosai, S.J., Serfecz, J., Morley, M.P., Gregory, B.D., Li, M., Reilly, M.P., Tissue-specific RNA-seq in human evoked inflammation identifies blood and adipose LincRNA signatures of cardiometabolic diseases. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 902–912.
84. Li, Z., Chao, T.-C., Chang, K.-Y., Lin, N., Patil, V.S., Shimizu, C., Head, S.R., Burns, J.C., Rana, T.M., The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. Proc. Natl. Acad. Sci. USA 111 (2014), 1002–1007.
85. Cui, H., Xie, N., Tan, Z., Banerjee, S., Thannickal, V.J., Abraham, E., Liu, G., The human long noncoding RNA lnc-IL7R regulates the inflammatory response. Eur. J. Immunol. 44 (2014), 2085–2095.
86. Krawczyk, M., Emerson, B.M., p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes. eLife, 3, 2014, e01776.
87. Chan, J., Atianand, M., Jiang, Z., Carpenter, S., Aiello, D., Elling, R., Fitzgerald, K.A., Caffrey, D.R., Cutting edge: a natural antisense transcript, AS-IL1α, controls inducible transcription of the proinflammatory cytokine IL-1α. J. Immunol. 195 (2015), 1359–1363.
88. Atianand, M.K., Hu, W., Satpathy, A.T., Shen, Y., Ricci, E.P., Alvarez-Dominguez, J.R., Bhatta, A., Schattgen, S.A., McGowan, J.D., Blin, J., et al. A long noncoding RNA lincRNA-EPS acts as a transcriptional brake to restrain inflammation. Cell 165 (2016), 1672–1685.
89. Reddy, M.A., Chen, Z., Park, J.T., Wang, M., Lanting, L., Zhang, Q., Bhatt, K., Leung, A., Wu, X., Putta, S., et al. Regulation of inflammatory phenotype in macrophages by a diabetes-induced long noncoding RNA. Diabetes 63 (2014), 4249–4261.
90. Puthanveetil, P., Chen, S., Feng, B., Gautam, A., Chakrabarti, S., Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells. J. Cell. Mol. Med. 19 (2015), 1418–1425.
91. Liu, J.Y., Yao, J., Li, X.M., Song, Y.C., Wang, X.Q., Li, Y.J., Yan, B., Jiang, Q., Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis., 5, 2014, e1506.
92. Yang, Y., Cai, Y., Wu, G., Chen, X., Liu, Y., Wang, X., Yu, J., Li, C., Chen, X., Jose, P.A., et al. Plasma long non-coding RNA, CoroMarker, a novel biomarker for diagnosis of coronary artery disease. Clin. Sci. 129 (2015), 675–685.
93. Cai, Y., Yang, Y., Chen, X., Wu, G., Zhang, X., Liu, Y., Yu, J., Wang, X., Fu, J., Li, C., et al. Circulating ‘lncRNA OTTHUMT00000387022’ from monocytes as a novel biomarker for coronary artery disease. Cardiovasc. Res. 112 (2016), 714–724.
94. Zhou, X., Han, X., Wittfeldt, A., Sun, J., Liu, C., Wang, X., Gan, L.M., Cao, H., Liang, Z., Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway. RNA Biol. 13 (2016), 98–108.
95. Townsend, N., Wilson, L., Bhatnagar, P., Wickramasinghe, K., Rayner, M., Nichols, M., Cardiovascular disease in Europe: epidemiological update 2016. Eur. Heart J. 37 (2016), 3232–3245.
96. Broadbent, H.M., Peden, J.F., Lorkowski, S., Goel, A., Ongen, H., Green, F., Clarke, R., Collins, R., Franzosi, M.G., Tognoni, G., et al., PROCARDIS consortium. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum. Mol. Genet. 17 (2008), 806–814.
97. Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., Jonasdottir, A., Sigurdsson, A., Baker, A., Palsson, A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316 (2007), 1491–1493.
98. McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D.R., Hinds, D.A., Pennacchio, L.A., Tybjaerg-Hansen, A., Folsom, A.R., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316 (2007), 1488–1491.
99. Folkersen, L., Kyriakou, T., Goel, A., Peden, J., Mälarstig, A., Paulsson-Berne, G., Hamsten, A., Hugh Watkins, Franco-Cereceda, A., Gabrielsen, A., Eriksson, P., PROCARDIS consortia. Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS ONE, 4, 2009, e7677.
100. Burd, C.E., Jeck, W.R., Liu, Y., Sanoff, H.K., Wang, Z., Sharpless, N.E., Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet., 6, 2010, e1001233.
101. Holdt, L.M., Stahringer, A., Sass, K., Pichler, G., Kulak, N.A., Wilfert, W., Kohlmaier, A., Herbst, A., Northoff, B.H., Nicolaou, A., et al. Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nat. Commun., 7, 2016, 12429.
102. Bochenek, G., Häsler, R., El Mokhtari, N.E., König, I.R., Loos, B.G., Jepsen, S., Rosenstiel, P., Schreiber, S., Schaefer, A.S., The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10. Hum. Mol. Genet. 22 (2013), 4516–4527.
103. Congrains, A., Kamide, K., Katsuya, T., Yasuda, O., Oguro, R., Yamamoto, K., Ohishi, M., Rakugi, H., CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC. Biochem. Biophys. Res. Commun. 419 (2012), 612–616.
104. Yap, K.L., Li, S., Muñoz-Cabello, A.M., Raguz, S., Zeng, L., Mujtaba, S., Gil, J., Walsh, M.J., Zhou, M.M., Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell 38 (2010), 662–674.
105. Kotake, Y., Nakagawa, T., Kitagawa, K., Suzuki, S., Liu, N., Kitagawa, M., Xiong, Y., Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 30 (2011), 1956–1962.
106. Congrains, A., Kamide, K., Oguro, R., Yasuda, O., Miyata, K., Yamamoto, E., Kawai, T., Kusunoki, H., Yamamoto, H., Takeya, Y., et al. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Atherosclerosis 220 (2012), 449–455.
107. Aguilo, F., Zhou, M.M., Walsh, M.J., Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Res. 71 (2011), 5365–5369.
108. Ishii, N., Ozaki, K., Sato, H., Mizuno, H., Saito, S., Takahashi, A., Miyamoto, Y., Ikegawa, S., Kamatani, N., Hori, M., et al. Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J. Hum. Genet. 51 (2006), 1087–1099.
109. Tsuiji, H., Yoshimoto, R., Hasegawa, Y., Furuno, M., Yoshida, M., Nakagawa, S., Competition between a noncoding exon and introns: Gomafu contains tandem UACUAAC repeats and associates with splicing factor-1. Genes Cells 16 (2011), 479–490.
110. Zangrando, J., Zhang, L., Vausort, M., Maskali, F., Marie, P.Y., Wagner, D.R., Devaux, Y., Identification of candidate long non-coding RNAs in response to myocardial infarction. BMC Genomics, 15, 2014, 460.
111. Kumarswamy, R., Bauters, C., Volkmann, I., Maury, F., Fetisch, J., Holzmann, A., Lemesle, G., de Groote, P., Pinet, F., Thum, T., Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ. Res. 114 (2014), 1569–1575.
112. de Gonzalo-Calvo, D., Kenneweg, F., Bang, C., Toro, R., van der Meer, R.W., Rijzewijk, L.J., Smit, J.W., Lamb, H.J., Llorente-Cortes, V., Thum, T., Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes. Sci. Rep., 6, 2016, 37354.
113. Vausort, M., Salgado-Somoza, A., Zhang, L., Leszek, P., Scholz, M., Teren, A., Burkhardt, R., Thiery, J., Wagner, D.R., Devaux, Y., Myocardial infarction-associated circular RNA predicting left ventricular dysfunction. J. Am. Coll. Cardiol. 68 (2016), 1247–1248.
114. Devaux, Y., Creemers, E.E., Boon, R.A., Werfel, S., Thum, T., Engelhardt, S., Dimmeler, S., Squire, I., Cardiolinc network. Circular RNAs in heart failure. Eur. J. Heart Fail. 19 (2017), 701–709.
115. Elia, L., Quintavalle, M., Condorelli, G., Circular RNAs and heart failure: new players for an old disease. Cardiovasc. Res. 113 (2017), 254–255.
116. Tan, W.L., Lim, B.T., Anene-Nzelu, C.G., Ackers-Johnson, M., Dashi, A., See, K., Tiang, Z., Lee, D.P., Chua, W.W., Luu, T.D., et al. A landscape of circular RNA expression in the human heart. Cardiovasc. Res. 113 (2017), 298–309.
117. Wang, K., Long, B., Liu, F., Wang, J.X., Liu, C.Y., Zhao, B., Zhou, L.Y., Sun, T., Wang, M., Yu, T., et al. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. Eur. Heart J. 37 (2016), 2602–2611.
118. Geng, H.H., Li, R., Su, Y.M., Xiao, J., Pan, M., Cai, X.X., Ji, X.P., The circular RNA Cdr1as promotes myocardial infarction by mediating the regulation of miR-7a on its target genes expression. PLoS ONE, 11, 2016, e0151753.
119. Yan, Y., Zhang, B., Liu, N., Qi, C., Xiao, Y., Tian, X., Li, T., Liu, B., Circulating long noncoding RNA UCA1 as a novel biomarker of acute myocardial infarction. BioMed Res. Int., 2016, 2016, 8079372.
120. Liu, Y., Zhou, D., Li, G., Ming, X., Tu, Yf., Tian, J., Lu, H., Yu, B., Long non coding RNA-UCA1 contributes to cardiomyocyte apoptosis by suppression of p27 expression. Cell. Physiol. Biochem. 35 (2015), 1986–1998.
121. Zolk, O., Solbach, T.F., Eschenhagen, T., Weidemann, A., Fromm, M.F., Activation of negative regulators of the hypoxia-inducible factor (HIF) pathway in human end-stage heart failure. Biochem. Biophys. Res. Commun. 376 (2008), 315–320.
122. Gottlieb, R.A., Mentzer, R.M., Autophagy during cardiac stress: joys and frustrations of autophagy. Annu. Rev. Physiol. 72 (2010), 45–59.
123. Ma, X., Liu, H., Foyil, S.R., Godar, R.J., Weinheimer, C.J., Hill, J.A., Diwan, A., Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation 125 (2012), 3170–3181.
124. Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X.H., Mizushima, N., Packer, M., Schneider, M.D., Levine, B., Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122 (2005), 927–939.
125. Wang, K., Liu, C.Y., Zhou, L.Y., Wang, J.X., Wang, M., Zhao, B., Zhao, W.K., Xu, S.J., Fan, L.H., Zhang, X.J., et al. APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat. Commun., 6, 2015, 6779.
126. Wang, K., Liu, F., Zhou, L.Y., Long, B., Yuan, S.M., Wang, Y., Liu, C.Y., Sun, T., Zhang, X.J., Li, P.F., The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ. Res. 114 (2014), 1377–1388.
127. Dangwal, S., Schimmel, K., Foinquinos, A., Xiao, K., Thum, T., Noncoding RNAs in heart failure. Handb. Exp. Pharmacol. 243 (2017), 423–445.
128. Wang, Z., Zhang, X.J., Ji, Y.X., Zhang, P., Deng, K.Q., Gong, J., Ren, S., Wang, X., Chen, I., Wang, H., et al. The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy. Nat. Med. 22 (2016), 1131–1139.
129. Han, P., Li, W., Lin, C.H., Yang, J., Shang, C., Nuernberg, S.T., Jin, K.K., Xu, W., Lin, C.Y., Lin, C.J., et al. A long noncoding RNA protects the heart from pathological hypertrophy. Nature 514 (2014), 102–106.
130. Jiang, F., Zhou, X., Huang, J., Long non-coding RNA-ROR mediates the reprogramming in cardiac hypertrophy. PLoS ONE, 11, 2016, e0152767.
131. Murtaza, I., Wang, H.X., Feng, X., Alenina, N., Bader, M., Prabhakar, B.S., Li, P.F., Down-regulation of catalase and oxidative modification of protein kinase CK2 lead to the failure of apoptosis repressor with caspase recruitment domain to inhibit cardiomyocyte hypertrophy. J. Biol. Chem. 283 (2008), 5996–6004.
132. Donath, S., Li, P., Willenbockel, C., Al-Saadi, N., Gross, V., Willnow, T., Bader, M., Martin, U., Bauersachs, J., Wollert, K.C., et al., German Heart Failure Network. Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress. Circulation 113 (2006), 1203–1212.
133. Zsebo, K., Yaroshinsky, A., Rudy, J.J., Wagner, K., Greenberg, B., Jessup, M., Hajjar, R.J., Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality. Circ. Res. 114 (2014), 101–108.
134. Gray, S.J., Samulski, R.J., Optimizing gene delivery vectors for the treatment of heart disease. Expert Opin. Biol. Ther. 8 (2008), 911–922.
135. White, K., Nicklin, S.A., Baker, A.H., Novel vectors for in vivo gene delivery to vascular tissue. Expert Opin. Biol. Ther. 7 (2007), 809–821.
136. Nathwani, A.C., Reiss, U.M., Tuddenham, E.G., Rosales, C., Chowdary, P., McIntosh, J., Della Peruta, M., Lheriteau, E., Patel, N., Raj, D., et al. Long-term safety and efficacy of factor IX gene therapy in hemophilia B. N. Engl. J. Med. 371 (2014), 1994–2004.
137. Kota, J., Chivukula, R.R., O'Donnell, K.A., Wentzel, E.A., Montgomery, C.L., Hwang, H.W., Chang, T.C., Vivekanandan, P., Torbenson, M., Clark, K.R., et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137 (2009), 1005–1017.
138. Montgomery, R.L., Yu, G., Latimer, P.A., Stack, C., Robinson, K., Dalby, C.M., Kaminski, N., van Rooij, E., MicroRNA mimicry blocks pulmonary fibrosis. EMBO Mol. Med. 6 (2014), 1347–1356.
139. Quattrocelli, M., Crippa, S., Montecchiani, C., Camps, J., Cornaglia, A.I., Boldrin, L., Morgan, J., Calligaro, A., Casasco, A., Orlacchio, A., et al. Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice. J. Am. Heart Assoc., 2, 2013, e000284.
140. Collins, M., Thrasher, A., Gene therapy: progress and predictions. Proc. Biol. Sci., 282, 2015, 20143003.
141. Jessup, M., Greenberg, B., Mancini, D., Cappola, T., Pauly, D.F., Jaski, B., Yaroshinsky, A., Zsebo, K.M., Dittrich, H., Hajjar, R.J., Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) Investigators. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 124 (2011), 304–313.
142. Robb, G.B., Brown, K.M., Khurana, J., Rana, T.M., Specific and potent RNAi in the nucleus of human cells. Nat. Struct. Mol. Biol. 12 (2005), 133–137.
143. Bennett, C.F., Swayze, E.E., RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu. Rev. Pharmacol. Toxicol. 50 (2010), 259–293.
144. Fluiter, K., Mook, O.R., Vreijling, J., Langkjaer, N., Højland, T., Wengel, J., Baas, F., Filling the gap in LNA antisense oligo gapmers: the effects of unlocked nucleic acid (UNA) and 4′-C-hydroxymethyl-DNA modifications on RNase H recruitment and efficacy of an LNA gapmer. Mol. Biosyst. 5 (2009), 838–843.
145. Lennox, K.A., Behlke, M.A., Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides. Nucleic Acids Res. 44 (2016), 863–877.
146. Fan, Y., Shen, B., Tan, M., Mu, X., Qin, Y., Zhang, F., Liu, Y., TGF-β-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin. Cancer Res. 20 (2014), 1531–1541.
147. Arun, G., Diermeier, S., Akerman, M., Chang, K.C., Wilkinson, J.E., Hearn, S., Kim, Y., MacLeod, A.R., Krainer, A.R., Norton, L., et al. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss. Genes Dev. 30 (2016), 34–51.
148. Gutschner, T., Hämmerle, M., Eissmann, M., Hsu, J., Kim, Y., Hung, G., Revenko, A., Arun, G., Stentrup, M., Gross, M., et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 73 (2013), 1180–1189.
149. Citti, L., Rainaldi, G., Synthetic hammerhead ribozymes as therapeutic tools to control disease genes. Curr. Gene Ther. 5 (2005), 11–24.
150. Su, J.Z., Fukuda, N., Hu, W.Y., Kanmatsuse, K., Ribozyme to human TGF-beta1 mRNA inhibits the proliferation of human vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 278 (2000), 401–407.
151. Pedram Fatemi, R., Salah-Uddin, S., Modarresi, F., Khoury, N., Wahlestedt, C., Faghihi, M.A., Screening for small-molecule modulators of long noncoding RNA-protein interactions using AlphaScreen. J. Biomol. Screen. 20 (2015), 1132–1141.
152. Huang, X., Yuan, T., Tschannen, M., Sun, Z., Jacob, H., Du, M., Liang, M., Dittmar, R.L., Liu, Y., Liang, M., et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics, 14, 2013, 319.
153. Deloukas, P., Kanoni, S., Willenborg, C., Farrall, M., Assimes, T.L., Thompson, J.R., Ingelsson, E., Saleheen, D., Erdmann, J., Goldstein, B.A., et al. CARDIoGRAMplusC4D Consortium DIAGRAM Consortium CARDIOGENICS Consortium MuTHER Consortium, Wellcome Trust Case Control Consortium. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 45 (2013), 25–33.
154. Pasmant, E., Sabbagh, A., Vidaud, M., Bièche, I., ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 25 (2011), 444–448.
155. Iacobucci, I., Sazzini, M., Garagnani, P., Ferrari, A., Boattini, A., Lonetti, A., Papayannidis, C., Mantovani, V., Marasco, E., Ottaviani, E., et al. A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia. Leuk. Res. 35 (2011), 1052–1059.
156. Diederichs, S., The four dimensions of noncoding RNA conservation. Trends Genet. 30 (2014), 121–123.
157. Kino, T., Hurt, D.E., Ichijo, T., Nader, N., Chrousos, G.P., Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci. Signal., 3, 2010, ra8.
158. Guo, X., Gao, L., Wang, Y., Chiu, D.K., Wang, T., Deng, Y., Advances in long noncoding RNAs: identification, structure prediction and function annotation. Brief. Funct. Genomics 15 (2016), 38–46.
159. Ding, Y., Tang, Y., Kwok, C.K., Zhang, Y., Bevilacqua, P.C., Assmann, S.M., In vivo genome-wide profiling of RNA secondary structure reveals novel regulatory features. Nature 505 (2014), 696–700.
160. Spitale, R.C., Crisalli, P., Flynn, R.A., Torre, E.A., Kool, E.T., Chang, H.Y., RNA SHAPE analysis in living cells. Nat. Chem. Biol. 9 (2013), 18–20.
161. Yang, K.C., Yamada, K.A., Patel, A.Y., Topkara, V.K., George, I., Cheema, F.H., Ewald, G.A., Mann, D.L., Nerbonne, J.M., Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation 129 (2014), 1009–1021.
162. Boeckel, J.N., Jaé, N., Heumüller, A.W., Chen, W., Boon, R.A., Stellos, K., Zeiher, A.M., John, D., Uchida, S., Dimmeler, S., Identification and characterization of hypoxia-regulated endothelial circular RNA. Circ. Res. 117 (2015), 884–890.
163. Aparicio-Prat, E., Arnan, C., Sala, I., Bosch, N., Guigó, R., Johnson, R., DECKO: single-oligo, dual-CRISPR deletion of genomic elements including long non-coding RNAs. BMC Genomics, 16, 2015, 846.
164. Müller, R., Weirick, T., John, D., Militello, G., Chen, W., Dimmeler, S., Uchida, S., ANGIOGENES: knowledge database for protein-coding and noncoding RNA genes in endothelial cells. Sci. Rep., 6, 2016, 32475.
165. Zhou, K.R., Liu, S., Sun, W.J., Zheng, L.L., Zhou, H., Yang, J.H., Qu, L.H., ChIPBase v2.0: decoding transcriptional regulatory networks of non-coding RNAs and protein-coding genes from ChIP-seq data. Nucleic Acids Res. 45 (2017), D43–D50.
166. Yang, J.H., Li, J.H., Jiang, S., Zhou, H., Qu, L.H., ChIPBase: a database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-seq data. Nucleic Acids Res. 41 (2013), D177–D187.
167. Zheng, L.L., Li, J.H., Wu, J., Sun, W.J., Liu, S., Wang, Z.L., Zhou, H., Yang, J.H., Qu, L.H., deepBase v2.0: identification, expression, evolution and function of small RNAs, lncRNAs and circular RNAs from deep-sequencing data. Nucleic Acids Res. 44 (2016), D196–D202.
168. Yang, J.H., Shao, P., Zhou, H., Chen, Y.Q., Qu, L.H., deepBase: a database for deeply annotating and mining deep sequencing data. Nucleic Acids Res. 38 (2010), D123–D130.
169. Mudge, J.M., Harrow, J., Creating reference gene annotation for the mouse C57BL6/J genome assembly. Mamm. Genome 26 (2015), 366–378.
170. Harrow, J., Frankish, A., Gonzalez, J.M., Tapanari, E., Diekhans, M., Kokocinski, F., Aken, B.L., Barrell, D., Zadissa, A., Searle, S., et al. GENCODE: the reference human genome annotation for the ENCODE Project. Genome Res. 22 (2012), 1760–1774.
171. Ning, S., Yue, M., Wang, P., Liu, Y., Zhi, H., Zhang, Y., Zhang, J., Gao, Y., Guo, M., Zhou, D., et al. LincSNP 2.0: an updated database for linking disease-associated SNPs to human long non-coding RNAs and their TFBSs. Nucleic Acids Res. 45 (2017), D74–D78.
172. Volders, P.J., Verheggen, K., Menschaert, G., Vandepoele, K., Martens, L., Vandesompele, J., Mestdagh, P., An update on LNCipedia: a database for annotated human lncRNA sequences. Nucleic Acids Res. 43 (2015), D174–D180.
173. Volders, P.J., Helsens, K., Wang, X., Menten, B., Martens, L., Gevaert, K., Vandesompele, J., Mestdagh, P., LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res. 41 (2013), D246–D251.
174. Quek, X.C., Thomson, D.W., Maag, J.L., Bartonicek, N., Signal, B., Clark, M.B., Gloss, B.S., Dinger, M.E., lncRNAdb v2.0: expanding the reference database for functional long noncoding RNAs. Nucleic Acids Res. 43 (2015), D168–D173.
175. Amaral, P.P., Clark, M.B., Gascoigne, D.K., Dinger, M.E., Mattick, J.S., lncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Res. 39 (2011), D146–D151.
176. Chen, G., Wang, Z., Wang, D., Qiu, C., Liu, M., Chen, X., Zhang, Q., Yan, G., Cui, Q., LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res. 41 (2013), D983–D986.
177. Bhartiya, D., Pal, K., Ghosh, S., Kapoor, S., Jalali, S., Panwar, B., Jain, S., Sati, S., Sengupta, S., Sachidanandan, C., et al. lncRNome: a comprehensive knowledgebase of human long noncoding RNAs. Database (Oxford), 2013, 2013, bat034.
178. Zhao, Y., Li, H., Fang, S., Kang, Y., Wu, W., Hao, Y., Li, Z., Bu, D., Sun, N., Zhang, M.Q., Chen, R., NONCODE 2016: an informative and valuable data source of long non-coding RNAs. Nucleic Acids Res. 44 (2016), D203–D208.